+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Disposable Syringes Market by Type, Needle Type, Capacity, Material, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336330
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Disposable Syringes Market grew from USD 17.04 billion in 2024 to USD 18.13 billion in 2025. It is expected to continue growing at a CAGR of 6.66%, reaching USD 25.09 billion by 2030.

Navigating the Disposable Syringes Market Landscape

Disposable syringes have emerged as foundational instruments within clinical settings, serving a pivotal role in administering medications, vaccinations, and diagnostics with precision and safety. Their single-use design effectively eliminates the risk of cross-contamination, reinforcing stringent infection control protocols and supporting both patient welfare and healthcare worker safety.

This executive summary offers a comprehensive exploration of the disposable syringes market, addressing transformative trends, tariff implications, segmentation dynamics, regional variations, and competitive strategies. Decision-makers will gain insights into evolving market drivers and actionable recommendations to navigate a landscape defined by regulatory rigor and technological innovation.

Emerging Forces Redefining the Disposable Syringes Sector

Over the past decade, regulatory frameworks have tightened around needlestick injuries and bloodborne pathogen transmission, driving accelerated adoption of safety-engineered syringes. Manufacturers are channeling resources into retractable syringe mechanisms and non-retractable safety designs to meet evolving standards and reduce occupational hazards. Concurrently, public health campaigns have heightened awareness of safe injection practices, catalyzing investments in devices that seamlessly integrate user-friendly safety features without compromising dosage accuracy.

Material innovation has emerged as another transformative force, with industry players exploring biodegradable and compostable polymers to address mounting environmental concerns. Glass-to-plastic substitution continues to shape manufacturing footprints, as plastic syringes offer lower production costs and enhanced breakage resistance. Additionally, the integration of digital technologies into syringe design-ranging from barcoded labels for traceability to connectivity modules for adherence monitoring-is setting the stage for the next generation of smart injection systems that align with broader healthcare digitization initiatives.

Assessing the 2025 US Tariffs on Syringe Trade Dynamics

Imposition of tariffs on imported disposable syringes in 2025 has redefined supply chain economics, prompting buyers to reassess sourcing strategies and inventory planning. Increased duties on key raw materials and finished products have elevated landed costs, compelling healthcare providers to negotiate volume-based contracts and explore alternative suppliers. This environment has also incentivized regional manufacturing expansions, as domestic producers seek to capture share by offering competitive pricing and reduced lead times.

The ripple effects extend to product innovation, as manufacturers optimize production efficiencies and material usage to mitigate cost pressures. While end users confront short-term pricing adjustments, the long-term impact may skew toward a more balanced trade ecosystem, with local production hubs strengthening resilience against tariff-driven volatility.

Deep Dive into Market Segmentation Drivers

Type-based analysis underscores a dichotomy between conventional and safety syringes. Within the conventional category, two-part and three-part configurations remain prevalent for general diagnostic and therapeutic applications, while specialized hypodermic, insulin, luer lock, and precision syringes cater to specific dosing and administration requirements. Safety syringes, divided into non-retractable and retractable variants, are gaining traction under stringent needlestick prevention mandates, with retractable models offering enhanced protection against accidental exposure.

Needle type segmentation reveals that hypodermic needles continue to dominate clinical usage, yet emerging micro-needle patches and blunt tip designs are carving out niches in cosmetic procedures and intradermal drug delivery. Fixed needles provide integrated stability for high-volume injections, whereas removable needles allow for flexible pairing with diverse syringe barrels, optimizing inventory management and application versatility. Capacity segmentation shows that standard volumes between one and twenty milliliters address most therapeutic and vaccination needs, while miniature syringes under one milliliter serve precision dosing in insulin delivery, and larger formats above twenty milliliters fulfill bulk applications in laboratory settings.

Material insights demonstrate a strong preference for plastic syringes, particularly those molded from polycarbonate, polyethylene, and polypropylene, driven by their cost-effectiveness and manufacturability. Glass syringes maintain a foothold in specialty applications requiring chemical inertness and reuse under sterilization protocols, and the emergence of biodegradable and compostable options reflects a growing emphasis on environmental stewardship.

Application-based dynamics highlight cosmetic, diagnostic, therapeutic, and vaccination uses, with therapeutic dispensing of drugs and insulin growing in tandem with chronic disease prevalence, and adult and childhood vaccination campaigns sustaining robust syringe demand. End-user segmentation shows that hospitals and clinics remain the principal consumers, followed by home healthcare settings where self-administration and convenience are paramount, diagnostic laboratories requiring precise sample handling, ambulatory surgical centers optimizing throughput, military and field medical units demanding portable reliability, and veterinary clinics addressing animal health markets.

Regional Market Trends Shaping Global Demand

In the Americas, robust healthcare infrastructure and extensive vaccination efforts underpin consistent demand for disposable syringes. The region’s mature market benefits from established domestic production facilities that can swiftly adjust output in response to policy shifts and tariff structures. Private and public payers are increasingly negotiating price concessions for high-volume procurement, fostering a competitive supplier landscape.

Europe, Middle East and Africa exhibits diverse market dynamics shaped by regional regulatory harmonization efforts and varying stages of healthcare development. Western European countries prioritize advanced safety-engineered syringes through stringent directives, while emerging markets in the Middle East and North Africa are ramping up immunization and therapeutic programs, stimulating incremental growth. Sub-Saharan Africa’s reliance on international aid and procurement agencies drives demand for cost-effective syringe solutions, often distributed through large-scale vaccination campaigns.

Asia-Pacific stands out as the fastest-growing region, propelled by expanding pharmaceutical manufacturing hubs, rising healthcare expenditure, and government-led vaccination initiatives. Nations such as India and China are not only major consumers but also key exporters of syringe products, leveraging low-cost production to serve both domestic and global markets. Meanwhile, increasing adoption of safety and smart syringe technologies in developed Asia-Pacific markets underscores the region’s trajectory toward innovation-led growth.

Competitive Landscape and Leading Players Strategies

Industry leaders are channeling significant R&D investments toward next-generation devices that integrate safety features and ergonomics. Becton Dickinson’s continued expansion of its safety syringe portfolio and Terumo’s launch of ultra-thin-wall hypodermic models exemplify this drive. Cardinal Health has enhanced its manufacturing footprint through strategic acquisitions, strengthening its ability to supply large healthcare networks with customized syringe solutions.

Partnerships between syringe producers and pharmaceutical companies are reshaping go-to-market strategies, enabling co-developed delivery systems tailored for specific therapies. Nipro’s collaboration on smart insulin pens and Smiths Medical’s joint ventures in emerging markets highlight the trend toward integrated value chains. Regional alliances are also gaining traction, as local manufacturers leverage global expertise to meet domestic demand while adhering to international quality standards.

Sustainability and digital connectivity are emerging as critical differentiators among top players. Investments in biodegradable polymers and closed-loop recycling programs signal a commitment to environmental responsibility. Concurrently, the integration of RFID tagging and connectivity modules for dosage monitoring reflects the strategic pivot toward data-driven healthcare solutions. These focused initiatives underscore the competitive landscape’s evolution toward innovation, compliance, and customer-centricity.

Strategic Imperatives for Market Leadership

To maintain competitive advantage, industry leaders should diversify supply chains by establishing regional manufacturing hubs that mitigate tariff exposure and reduce logistical dependencies. Proximity to key markets not only curtails lead times but also fosters stronger relationships with local healthcare providers and regulatory bodies.

Investment in safety-engineered and smart syringe technologies must remain a priority. By accelerating the development of retractable mechanisms and embedding connectivity features for traceability and adherence tracking, manufacturers can align with evolving clinical requirements and digital health trends. Strategic alliances with technology firms and healthcare institutions will accelerate market entry and adoption.

Sustainability initiatives should be integrated into product design and production processes. Transitioning to biodegradable materials and implementing take-back or closed-loop recycling programs will address environmental concerns and enhance brand reputation among eco-aware stakeholders. Collaborative research with polymer scientists and waste management entities can drive scalable solutions.

Proactive engagement with regulators and end users is essential to anticipate policy shifts and shape product standards. Participating in standards committees and conducting targeted field trials with hospitals, home healthcare providers, and veterinary clinics will generate real-world feedback, inform product roadmaps, and solidify market positioning.

Rigorous Methodology Ensuring Data Integrity

This report synthesizes insights through a rigorous multi-phase research methodology combining primary and secondary data sources. Extensive interviews with industry executives, procurement specialists, clinicians, and regulatory experts provided firsthand perspectives on market drivers, product adoption, and emerging challenges across global regions.

Secondary research encompassed a comprehensive review of peer-reviewed journals, regulatory filings, trade association publications, and corporate disclosures. Market intelligence databases and industry reports supplemented this foundation, ensuring a robust contextual understanding of historical trends and competitive dynamics.

Quantitative data were analyzed using statistical modeling to discern patterns in consumption, material usage, and pricing. Qualitative content analysis of expert testimony and policy documents enabled interpretation of regulatory shifts and technology adoption trajectories. Data triangulation techniques cross-verified findings, enhancing accuracy and reliability.

Segmentation analyses were performed by categorizing market variables into syringe types, needle configurations, capacity ranges, material classifications, application areas, and end-user channels. Regional and tariff impact assessments were grounded in trade flow data and government policy announcements. This methodological framework ensures that conclusions and recommendations are evidence-based and actionable.

Concluding Perspectives on the Disposable Syringes Market

Disposable syringes represent a dynamic intersection of safety imperatives, material innovation, and regulatory oversight. Heightened demand for safety-engineered and smart delivery systems is reshaping product portfolios, while material shifts toward biodegradable and compostable polymers signal a growing sustainability consciousness. The 2025 tariff landscape has accelerated regional manufacturing realignment, underscoring the importance of supply chain resilience.

Segmentation insights reveal that diverse syringe types, needle designs, and capacity offerings must be tailored to distinct clinical and laboratory applications. Regional variations in infrastructure, policy, and procurement models are driving differentiated growth trajectories across the Americas, Europe, Middle East and Africa, and Asia-Pacific. Competitive pressures are catalyzing strategic partnerships, digital integration, and eco-friendly initiatives among leading firms.

Looking ahead, manufacturers that invest in innovation, localize production, and engage proactively with stakeholders will secure leadership in this evolving market. The path forward demands agility, collaboration, and a commitment to delivering safe, efficient, and sustainable injection solutions.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Conventional Syringes
      • 2-Part Syringes
      • 3-Part Syringes
      • Hypodermic Syringes
      • Insulin Syringes
      • Luer Lock Syringes
      • Precision Syringes
    • Safety Syringes
      • Non-Retractable Safety Syringes
      • Retractable Safety Syringes
  • Needle Type
    • Blunt Tip Needle
    • Fixed Needle
    • Hypodermic Needle
    • Micro-needle
    • Removable Needle
  • Capacity
    • 1 mL-20 mL
    • < 1 mL
    • >20 mL
  • Material
    • Biodegradable/Compostable Materials
    • Glass Syringes
    • Plastic Syringes
      • Polycarbonate
      • Polyethylene
      • Polypropylene
  • Application
    • Cosmetics
    • Diagnostic
    • Therapeutic
      • Drug Delivery
      • Insulin Delivery
    • Vaccination
      • Adult Vaccination
      • Childhood Vaccination
  • End User
    • Ambulatory Surgical Centers
    • Diagnostic Laboratories
    • Home Healthcare
    • Hospitals & Clinics
    • Military & Field Medical Units
    • Veterinary Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • AdvaCare Pharma
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Cole-Parmer Instrument Company, LLC
  • Fresenius Kabi AG
  • GPE Group
  • Henke Sass Wolf GmbH
  • Hindustan Syringes & Medical Devices Ltd.
  • Hu-Friedy Mfg Co, LLC by Cantel Medical Corporation
  • ICU Medical, Inc.
  • ISCON SURGICALS LTD.
  • Jiangsu Shenli Medical Production Co., Ltd.
  • KD Medical GmbH Hospital Products
  • Nipro Corporation
  • Novo Nordisk A/S
  • Retractable Technologies, Inc.
  • Shree Umiya Surgical Pvt. Ltd.
  • Taizhou Sanxin Medical Technology Co., Ltd.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • UltiMed, Inc.
  • Vita Needle Company
  • Weigao Meidcal international Co., Ltd
  • Yangzhou Medline Industry Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Disposable Syringe Market at a Crossroads of Innovation and Demand
3.2. Navigating Consumer Preferences and Competitive Forces
3.3. Lifecycle and Intellectual Property Blueprint for Strategic Growth
3.4. Phases of Expansion, Strategic Growth, and Emerging Opportunities
4. Market Overview
4.1. Introduction
4.1.1. Driving Forces and Innovation Pathways in the Global Disposable Syringes Market
4.1.2. Regional Dynamics Shaping Disposable Syringe Adoption Worldwide
4.1.3. Cutting-Edge Developments and Collaborations in Disposable Syringe Technology
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in digital tracking features for prefilled syringes enhancing medication monitoring
5.1.1. Digital Tracking Integration Redefines Syringe Transparency
5.1.2. Strategic Imperatives for Embracing Smart Prefilled Syringes
5.1.3. Future Trajectory of Digital Tracking in Prefilled Syringes
5.2. Growing adoption of safety engineered auto-disable syringes in immunization programs
5.2.1. Safety Engineered Auto-Disable Syringes Redefining Immunization Safety
5.2.2. Unlocking Innovation and Demand in the Auto-Disable Syringe Market
5.2.3. Anticipating the Evolution and Challenges of Auto-Disable Syringe Adoption
5.3. Rising popularity of prefilled injectable formulations in specialty biotech therapies fueling delivery efficiency
5.3.1. Defining the Surge of Prefilled Injectables in Biotech Therapies
5.3.2. Transformative Impact of Prefilled Formats on Market Dynamics
5.3.3. Anticipating the Evolution and Strategic Implications
5.4. Integration of biodegradable polymers to address environmental concerns in syringe disposal
5.4.1. Shifting to Nature-Friendly Syringes with Biodegradable Polymers
5.4.2. Revolutionizing the Syringe Market Through Sustainable Materials
5.4.3. Future Pathways and Risks for Biopolymer Syringe Adoption
5.5. Collaborations among pharmaceutical companies and device manufacturers accelerating custom syringe designs
5.5.1. Pharma-Device Alliances Driving Customized Syringe Innovations
5.5.2. Recalibrating Strategies to Embrace Collaborative Design Models
5.5.3. The Future Trajectory of Tailored Syringe Partnerships
5.6. Growing demand for prefilled syringe delivery systems in biotech and specialty drug therapies
5.6.1. Acceleration of Prefilled Syringes Driven by Biotech Innovations
5.6.2. Strategic Realignment for Biotech Firms Embracing Prefilled Delivery
5.6.3. Future Trajectory of Prefilled Syringe Adoption in Specialty Therapies
5.7. Expanding use of auto-disable safety syringes in global vaccination drives reducing needle reuse
5.7.1. Drivers Fueling the Surge of Auto-Disable Safety Syringes in Vaccination Campaigns
5.7.2. Strategic Shifts to Align with Rising Demand for Auto-Disable Devices
5.7.3. The Future Landscape Shaped by Auto-Disable Safety Syringes
5.8. Development of eco-friendly syringe production using plant-based biodegradable materials for waste management
5.8.1. Eco-Friendly Syringes Gain Traction as Waste Management Imperative
5.8.2. Reinventing Strategies for Biodegradable Syringe Production and Market Positioning
5.8.3. Forecasting the Future of Plant-Based Biodegradable Syringes
5.9. Integration of smart RFID and barcode tracking in prefilled syringes improving patient compliance
5.9.1. Revolutionizing Prefilled Syringes with RFID and Barcode Intelligence
5.9.2. New Horizons: Market Transformation Through Smart Syringe Tracking
5.9.3. Future Outlook and Strategic Considerations for Smart Syringe Tracking
5.10. Auto-disable safety syringes scaling up in large-scale vaccination campaigns
5.10.1. Driving Forces Behind the Surge in Auto-Disable Syringes
5.10.2. Strategic Shifts Required to Embrace Safety Syringe Adoption
5.10.3. Future Trajectory of Safety Syringes in Mass Vaccination
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.1.1. Steep Entry Hurdles Guarding the Syringe Market
6.1.2. Alternative Delivery Methods Challenging Traditional Syringes
6.1.3. Specialized Inputs Shaping Supplier Leverage
6.1.4. Healthcare Purchasers Driving Syringe Value Demands
6.1.5. High-Stakes Competition in a Commoditized Syringe Arena
6.2. PESTLE Analysis
6.2.1. Regulatory Dynamics and Geopolitical Stability Shaping Syringe Supply Chains
6.2.2. Cost Pressures and Currency Fluctuations Influencing Pricing Strategies
6.2.3. Demographic Shifts and Patient Safety Concerns Driving Demand
6.2.4. Innovations in Syringe Design and Manufacturing Automation Accelerate Efficiency
6.2.5. Stringent Medical Device Regulations Elevating Compliance Mandates
6.2.6. Sustainability Imperatives and Waste Management Challenges
7. Cumulative Impact of United States Tariffs 2025
7.1. Trade Barriers Taking Aim at Disposables
7.2. Roots of America’s Tariff Playbook
7.3. Tariffs Adding to Global Price Pressures
7.4. Escalation of Reciprocal Tariff Battles
7.5. Ripples Felt Across Key Trading Partners
7.6. Shifts in Supply Chains and Consumer Choices
7.7. Charting a Path Beyond Tariff Turbulence
8. Disposable Syringes Market, by Type
8.1. Introduction
8.2. Conventional Syringes
8.2.1. 2-Part Syringes
8.2.2. 3-Part Syringes
8.2.3. Hypodermic Syringes
8.2.4. Insulin Syringes
8.2.5. Luer Lock Syringes
8.2.6. Precision Syringes
8.3. Safety Syringes
8.3.1. Non-Retractable Safety Syringes
8.3.2. Retractable Safety Syringes
9. Disposable Syringes Market, by Needle Type
9.1. Introduction
9.2. Blunt Tip Needle
9.3. Fixed Needle
9.4. Hypodermic Needle
9.5. Micro-needle
9.6. Removable Needle
10. Disposable Syringes Market, by Capacity
10.1. Introduction
10.2. 1 mL-20 mL
10.3. < 1 mL
10.4. >20 mL
11. Disposable Syringes Market, by Material
11.1. Introduction
11.2. Biodegradable/Compostable Materials
11.3. Glass Syringes
11.4. Plastic Syringes
11.4.1. Polycarbonate
11.4.2. Polyethylene
11.4.3. Polypropylene
12. Disposable Syringes Market, by Application
12.1. Introduction
12.2. Cosmetics
12.3. Diagnostic
12.4. Therapeutic
12.4.1. Drug Delivery
12.4.2. Insulin Delivery
12.5. Vaccination
12.5.1. Adult Vaccination
12.5.2. Childhood Vaccination
13. Disposable Syringes Market, by End User
13.1. Introduction
13.2. Ambulatory Surgical Centers
13.3. Diagnostic Laboratories
13.4. Home Healthcare
13.5. Hospitals & Clinics
13.6. Military & Field Medical Units
13.7. Veterinary Clinics
14. Americas Disposable Syringes Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Disposable Syringes Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Disposable Syringes Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AdvaCare Pharma
17.3.1.1. From Regional Producer to Global Challenger in High-Volume Syringe Supply
17.3.1.2. Engineering Safety and Affordability into Core Syringe Technologies
17.3.1.3. Mitigating Supply, Regulatory, and Competitive Pressures for Sustainable Growth
17.3.2. B. Braun SE
17.3.2.1. Path to Innovating and Excelling Prominence in the Disposable Syringe Arena
17.3.2.2. Flagship Syringe Solutions Empowering Safe and Efficient Care Worldwide
17.3.2.3. Safeguarding Growth Against Emerging Vulnerabilities in the Disposable Syringes Market
17.3.3. Baxter International, Inc.
17.3.3.1. Charting Baxter’s Journey to Syringe Market Dominance
17.3.3.2. Defining Innovation Through Baxter’s Signature Syringe Platforms
17.3.3.3. Fortifying Baxter’s Future by Mitigating Strategic Vulnerabilities
17.3.4. Becton, Dickinson and Company
17.3.4.1. Pioneering Precision: BD’s Commanding Role in the Syringe Market
17.3.4.2. Precision in Practice: BD’s Flagship Syringe Portfolio and Competitive Edge
17.3.4.3. Navigating Headwinds: Strategic Roadmap to Strengthen BD’s Position
17.3.5. Cole-Parmer Instrument Company, LLC
17.3.5.1. From Laboratory Roots to Global Syringe Market Leader
17.3.5.2. Precision and Performance in Syringe Solutions
17.3.5.3. Mitigating Risks and Fortifying Future Growth
17.3.6. Fresenius Kabi AG
17.3.6.1. From Inception to Industry Pillar in the Syringe Market
17.3.6.2. Inside the Innovation of Core Syringe Solutions
17.3.6.3. Navigating Risks and Fortifying Competitive Strength
17.3.7. GPE Group
17.3.7.1. From Niche Entrant to Global Challenger: GPE Group’s Market Evolution
17.3.7.2. Advancing Safety and Usability with Innovative Syringe Designs
17.3.7.3. Securing Future Growth by Mitigating Risks and Enhancing Differentiation
17.3.8. Henke Sass Wolf GmbH
17.3.8.1. From Precision Roots to Global Safety Solutions
17.3.8.2. Designing Tomorrow’s Injection Standards
17.3.8.3. Fortifying Growth Amidst Industry Headwinds
17.3.9. Hindustan Syringes & Medical Devices Ltd.
17.3.9.1. From Glass Beginnings to Global Leader in Disposable Disposal Strategies
17.3.9.2. Safety First: the Engineering Behind Its Flagship Syringe Innovations
17.3.9.3. Fortifying Future Growth by Tackling Cost, Compliance, and Competition
17.3.10. Hu-Friedy Mfg Co, LLC by Cantel Medical Corporation
17.3.10.1. Forged in Precision: Hu-Friedy’s Global Dental and Sterilization Leadership
17.3.10.2. Ergonomic Instrumentation and Traceability: Defining the Flagship Portfolio
17.3.10.3. Addressing Market Threats Through Innovation, Diversification, and Alliances
17.3.11. ICU Medical, Inc.
17.3.11.1. Pioneering Safety-Focused Infusion Solutions on a Global Scale
17.3.11.2. Flagship Infusion and Safety Platforms Delivering Clinical Excellence
17.3.11.3. Navigating Regulatory, Supply Chain, and Competitive Headwinds
17.3.12. ISCON SURGICALS LTD.
17.3.12.1. Quality-Driven Market Leadership and Global Footprint
17.3.12.2. Precision-Engineered Syringes Redefining Safety Standards
17.3.12.3. Navigating Threats and Seizing Growth Pathways
17.3.13. Jiangsu Shenli Medical Production Co., Ltd.
17.3.13.1. From Humble Beginnings to a Global Challenger in Disposable Syringes
17.3.13.2. Innovative Safety Auto-Disable and Prefilled Syringes Tailored to Public Health Needs
17.3.13.3. Addressing Regulatory, Competitive, and Supply Chain Risks to Secure Future Growth
17.3.14. KD Medical GmbH Hospital Products
17.3.14.1. Defining a Leading Presence in Hospital Injection Solutions
17.3.14.2. Delivering Flagship Syringes with Safety and Precision at the Forefront
17.3.14.3. Mitigating Risks and Seizing Innovation to Strengthen Market Position
17.3.15. Nipro Corporation
17.3.15.1. From Precision Beginnings to Global Reach: Nipro’s Market Evolution
17.3.15.2. Innovative Safety and Sterility: Nipro’s Flagship Syringe Solutions
17.3.15.3. Mitigating Threats and Strengthening Resilience for Future Growth
17.3.16. Novo Nordisk a/S
17.3.16.1. Charting Novo Nordisk’s Evolution into a Global Therapeutics Leader
17.3.16.2. Revolutionizing Care with GLP-1 Therapies and Integrated Delivery Systems
17.3.16.3. Addressing Risks and Fortifying Novo Nordisk’s Competitive Edge
17.3.17. Retractable Technologies, Inc.
17.3.17.1. Precision Positioning in Global Safety-Engineered Syringe Markets
17.3.17.2. Transformative Syringe Innovations Shaping Clinical Safety Standards
17.3.17.3. Mitigating Headwinds and Accelerating Portfolio Expansion
17.3.18. Shree Umiya Surgical Pvt. Ltd.
17.3.18.1. From Humble Beginnings to a Global Challenger in Syringe Manufacturing
17.3.18.2. Safety-First Syringes Engineered for Precision and Comfort
17.3.18.3. Mitigating Disruptions and Reinforcing Innovation for Sustained Growth
17.3.19. Taizhou Sanxin Medical Technology Co., Ltd.
17.3.19.1. Pioneering Safe Injection: Taizhou Sanxin’s Market Journey
17.3.19.2. Flagship Syringes Empowering Precision and Safety
17.3.19.3. Navigating Risks to Fortify Future Growth
17.3.20. Terumo Corporation
17.3.20.1. Forging a Global Leadership in Precision Injection Solutions
17.3.20.2. Revolutionizing Safety and Efficiency with Flagship Syringe Lines
17.3.20.3. Navigating Threats and Seizing Growth in a Transforming Healthcare Landscape
17.3.21. Thermo Fisher Scientific Inc.
17.3.21.1. Establishing Market Leadership through Core Strengths and Strategic Positioning
17.3.21.2. Innovative Disposable Syringe Solutions Tailored to Customer Needs
17.3.21.3. Mitigating Risks and Leveraging Trends for Future Growth
17.3.22. UltiMed, Inc.
17.3.22.1. UltiMed's Market Footprint and Core Strengths in Disposable Syringes
17.3.22.2. Flagship Syringe Solutions Tailored to Clinician and Patient Needs
17.3.22.3. Mitigating Risks and Driving Innovation for Sustainable Growth
17.3.23. Vita Needle Company
17.3.23.1. From Startup to Industry Challenger: Vita Needle’s Market Journey
17.3.23.2. Innovating Safety and Precision with Vita’s Flagship Syringes
17.3.23.3. Fortifying Future Growth by Mitigating Risks and Strengthening Core Weaknesses
17.3.24. Weigao Meidcal international Co., Ltd
17.3.24.1. Strategic Evolution from Pioneer to Global Contender
17.3.24.2. Innovative Injection Solutions Empower Clinical Efficiency
17.3.24.3. Mitigating Challenges to Sustain Market Leadership
17.3.25. Yangzhou Medline Industry Co., Ltd.
17.3.25.1. Strategic Landscape and Core Strengths in the Global Syringes Market
17.3.25.2. Flagship Syringe Innovations Aligned with Clinical Needs
17.3.25.3. Mitigating Growth Risks through Diversification and Technological Advances
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DISPOSABLE SYRINGES MARKET MULTI-CURRENCY
FIGURE 2. DISPOSABLE SYRINGES MARKET MULTI-LANGUAGE
FIGURE 3. DISPOSABLE SYRINGES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DISPOSABLE SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DISPOSABLE SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DISPOSABLE SYRINGES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DISPOSABLE SYRINGES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DISPOSABLE SYRINGES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY 2-PART SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY 3-PART SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY HYPODERMIC SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY LUER LOCK SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY PRECISION SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY NON-RETRACTABLE SAFETY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY RETRACTABLE SAFETY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY BLUNT TIP NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY FIXED NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY HYPODERMIC NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY MICRO-NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY REMOVABLE NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY 1 ML-20 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY < 1 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY >20 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY BIODEGRADABLE/COMPOSTABLE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY GLASS SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY ADULT VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY CHILDHOOD VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY MILITARY & FIELD MEDICAL UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DISPOSABLE SYRINGES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DISPOSABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES DISPOSABLE SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 81. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 82. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 84. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 85. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 86. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 88. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 93. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 95. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 96. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 97. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 99. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 100. MEXICO DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 148. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 149. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 151. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 152. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 153. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 155. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 156. GERMANY DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 159. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 160. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 161. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 162. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 163. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 164. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 166. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 167. FRANCE DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 181. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 182. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 183. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 184. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 185. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 186. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 188. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 189. ITALY DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 192. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 193. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 194. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 195. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 196. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 197. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 199. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 200. SPAIN DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 235. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 236. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 237. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 238. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 239. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 240. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 241. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 243. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 244. DENMARK DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 258. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 259. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 260. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 261. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 262. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 263. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 265. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 266. QATAR DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 268. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 269. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 270. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 271. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 272. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 273. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 274. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 276. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 277. FINLAND DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 287. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 299. NIGERIA DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 301. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 302. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 303. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 304. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 305. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 306. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 307. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 309. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 310. EGYPT DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 312. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 313. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 314. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 315. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 316. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 317. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 318. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 320. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 321. TURKEY DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 324. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 325. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 326. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 327. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 328. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 329. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 331. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 334. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 335. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY SAFETY SYRINGES, 2018-2030 (USD MILLION)
TABLE 336. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY NEEDLE TYPE, 2018-2030 (USD MILLION)
TABLE 337. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 338. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 339. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY PLASTIC SYRINGES, 2018-2030 (USD MILLION)
TABLE 340. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 341. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 342. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
TABLE 343. NORWAY DISPOSABLE SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 344. POLAND DISPOSABLE SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 345. POLAND DISPOSABLE SYRINGES MARKET SIZE, BY CONVENTIONAL SYRINGES, 2018-2030 (USD MILLION)
TABLE 346. POLAND DISPOSABLE S

Companies Mentioned

The companies profiled in this Disposable Syringes market report include:
  • AdvaCare Pharma
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Cole-Parmer Instrument Company, LLC
  • Fresenius Kabi AG
  • GPE Group
  • Henke Sass Wolf GmbH
  • Hindustan Syringes & Medical Devices Ltd.
  • Hu-Friedy Mfg Co, LLC by Cantel Medical Corporation
  • ICU Medical, Inc.
  • ISCON SURGICALS LTD.
  • Jiangsu Shenli Medical Production Co., Ltd.
  • KD Medical GmbH Hospital Products
  • Nipro Corporation
  • Novo Nordisk A/S
  • Retractable Technologies, Inc.
  • Shree Umiya Surgical Pvt. Ltd.
  • Taizhou Sanxin Medical Technology Co., Ltd.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • UltiMed, Inc.
  • Vita Needle Company
  • Weigao Meidcal international Co., Ltd
  • Yangzhou Medline Industry Co., Ltd.

Methodology

Loading
LOADING...

Table Information